Table 7.
lncRNA_ID | mRNA | Co-expression | Co-location (lncRNA to mRNA) | |||
---|---|---|---|---|---|---|
ID | Gene name | Pearson correlation | P-value | Distance | Location | |
D/E-1.46 vs. D/E-0.61 | ||||||
XR_523541.1 | 103398853 | Solute carrier family 16, member 5 (slc16a5) | 0.990 | 3.82E-07 | 200 | Downstream |
XR_521587.1 | 103379464 | Zinc finger protein 319-like (zfp319) | 0.972 | 1.24E-05 | 19594 | Upstream |
XR_523068.1 | 103393985 | Apolipoprotein A-IV-like (apoa4) | 0.953 | 7.22E-05 | 67904 | Downstream |
XR_521789.1 | 103381395 | Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 (mthfd1) | 0.986 | 1.06E-06 | 54 | Downstream |
LNC_000230 | 103381775 | Sideroflexin 2 (sfxn2) | 0.961 | 3.79E-05 | 52923 | Downstream |
LNC_000230 | 103381769 | Suppressor of cytokine signaling 3-like (scs3) | 0.955 | 6.09E-05 | 191 | Upstream |
LNC_000285 | 103385419 | Bromodomain adjacent to zinc finger domain 2A (baz2a) | 0.958 | 4.60E-05 | 837 | Downstream |
LNC_000587 | 103398248 | Chymotrypsin-like elastase family member 2A (ce2a) | 0.970 | 1.46E-05 | 4443 | Downstream |
XR_522182.1 | 103385102 | Lysine (K)-specific methyltransferase 2D (kmt2d) | −0.987 | 9.01E-07 | 74060 | Downstream |
XR_522818.1 | 103391927 | Uncharacterized LOC103391927 | 0.957 | 5.37E-05 | 17005 | Downstream |
LNC_000360 | 103388031 | Zinc finger protein 585A-like (zfp585a) | 0.968 | 1.88E-05 | 67207 | Downstream |
LNC_000360 | 103387998 | Zinc finger protein 574 (zfp574) | 0.957 | 5.02E-05 | 98036 | Upstream |
LNC_000562 | 103397059 | Methylcytosine dioxygenase TET3-like (mdtet3) | 0.957 | 5.33E-05 | 746 | Downstream |
LNC_000314 | 103386594 | Polyhomeotic-like protein 2 (php2) | 0.959 | 4.23E-05 | 33381 | Downstream |
LNC_000314 | 103386602 | Ribosomal protein S10 (rps10) | −0.968 | 1.87E-05 | 69929 | Upstream |
LNC_000255 | 103384010 | Up-regulated during skeletal muscle growth 5 homolog (usmg5) | 0.973 | 9.75E-06 | 91044 | Downstream |
XR_523487.1 | 103398370 | Sodium/potassium/calcium exchanger 1-like (spc1) | 0.951 | 8.46E-05 | 82748 | Upstream |
D/E-2.75 vs. D/E-0.61 | ||||||
XR_523541.1 | 103398853 | Solute carrier family 16, member 5 (slc16a5) | 0.990 | 3.82E-07 | 200 | Downstream |
XR_523068.1 | 103393985 | Apolipoprotein A-IV-like (apoa4) | 0.953 | 7.22E-05 | 67904 | Downstream |
XR_521789.1 | 103381395 | Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 (mthfd1) | 0.990 | 1.06E-06 | 54 | Downstream |
LNC_000230 | 103381775 | Sideroflexin 2 (sfxn2) | 0.961 | 3.79E-05 | 52923 | Downstream |
LNC_000230 | 103381769 | Suppressor of cytokine signaling 3-like (scs3) | 0.955 | 6.09E-05 | 191 | Upstream |
LNC_000285 | 103385419 | Bromodomain adjacent to zinc finger domain 2A (baz2a) | 0.958 | 4.60E-05 | 837 | Downstream |
LNC_000587 | 103398248 | Chymotrypsin-like elastase family member 2A (ce2a) | 0.952 | 7.35E-05 | 4443 | Downstream |
XR_522182.1 | 103385102 | Lysine (K)-specific methyltransferase 2D (kmt2d) | −0.987 | 9.01E-07 | 74060 | Downstream |
XR_522818.1 | 103391927 | Uncharacterized LOC103391927 | 0.957 | 5.37E-05 | 17005 | Downstream |
LNC_000360 | 103388031 | Zinc finger protein 585A-like (zfp585a) | 0.968 | 1.88E-05 | 67207 | Downstream |
LNC_000314 | 103386594 | Polyhomeotic-like protein 2 (php2) | 0.959 | 4.23E-05 | 33381 | Downstream |
LNC_000314 | 103386602 | Ribosomal protein S10 (rps10) | −0.968 | 1.87E-05 | 69929 | Upstream |
LNC_000255 | 103384010 | Up-regulated during skeletal muscle growth 5 homolog (usmg5) | 0.973 | 9.75E-06 | 91044 | Downstream |
D/E-1.46 vs. D/E-2.75 | ||||||
XR_523541.1 | 103398853 | Solute carrier family 16, member 5 (slc16a5) | 0.990 | 3.82E-07 | 200 | Downstream |
XR_521587.1 | 103379464 | Zinc finger protein 319-like (zfp319) | 0.972 | 1.24E-05 | 19594 | Upstream |
LNC_000285 | 103385419 | Bromodomain adjacent to zinc finger domain 2A (baz2a) | 0.958 | 4.60E-05 | 837 | Downstream |
LNC_000562 | 103397059 | Methylcytosine dioxygenase TET3-like (mdtet3) | 0.957 | 5.33E-05 | 746 | Downstream |
Minus values in Pearson correlation denote negative correlation, i.e., “mRNA up-regulated but lncRNA down-regulated” or “mRNA down-regulated but lncRNA up-regulated.”